Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Current

    • MeiraGTx Holdings Virtual KOL Event: Long-term data presentation for AAV-hAQP1 program for the treatment of Grade 2/3 Radiation-Induced Xerostomia

    The event will provide the full 3-year data from all cohorts of the open label Phase 1 study of MeiraGTx's…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Alterity Therapeutics Virtual KOL Event to Review and Share New Insights on ATH434 for the Treatment of Multiple System Atrophy

    Join Alterity Therapeutics for a virtual key opinion leader (KOL) event featuring Roy Freeman, MD (Harvard Medical School, Beth Israel Deaconess…
    TIME: 1:00 PM EDT
    LOCATION: Virtual
    View Details

    • Eupraxia Pharmaceuticals Virtual Investor Event at DDW 2026 to Discuss EP-104GI and Unmet Needs In The Prevention of Esophageal Strictures

    Join Eupraxia Pharmaceuticals for a virtual investor event at Digestive Disease Week (DDW) held May 2-5, 2026, in Chicago, Illinois.…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Trevi Therapeutics In-Person and Virtual Investor and Analyst Event to Discuss the Company’s Clinical and Commercial Strategy, Featuring KOLs in Chronic Cough

    Please join Trevi Therapeutics for its Investor and Analyst Day in Midtown, New York. During the program, Trevi's leadership team…
    TIME: 10:00 AM EDT
    LOCATION: Midtown, New York and Live Webcast
    View Details

    BioVie Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson’s Disease ahead of Topline Data in 2Q26

    Join BioVie Inc. for a virtual key opinion leader (KOL) event featuring Suzanne de la Monte, MD, MPH (Brown University Warren…
    TIME: 2:00 PM EDT
    LOCATION: Virtual
    View Details